Bridging the Gap

We believe that access to innovative medicines can transform outcomes for patients.

Our research

Our Bridging the Gap work looks at global trends in the development of medicines and access processes. The series of reports set out recommended policy solutions that aim to help create a more accessible pathway to ensure patients can get access to new innovative treatments quicker.

Bridging the Gap 3.0

Exploring the evolution of medicine regulatory policy in the UK.

Our research identifies trends in the global medicines regulatory environment. In this report we explore policy solutions that could enable the creation of innovative approaches to medicines regulation in the UK which supports early patient access to new, innovative treatments.

Read the full report here

Bridging the Gap 2.0

Our original reports explore policy solutions that could overcome delays in UK medicines’ appraisal stage of the access pathway. The research considers international approaches that support the acceleration of new and innovative medicines to patients.

England

Scotland